SUSMAN SALLY
SEC CIK 1263544 · EDGAR
BoughtSold
Most active insiders at FLUT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Jackson Jeremy Peter | CEO, Dir | $244.7K | $1.14M |
| 2 | Howe Amy | CEO, Pres - FanDuel | — | $942.1K |
| 3 | Coldrake Robert | CFO | — | $573.6K |
| 4 | Taylor Daniel Mark | Pres FLUT, CEO FLUT Intl | $251.6K | $77.4K |
| 5 | LIU DON H | CLO | $150.0K | $172.8K |
| 6 | BRYANT JOHN A | Dir | $200.6K | $20.3K |
| 7 | Bishop James Philip | COO | $99.8K | $72.5K |
| 8 | Lennon Carolan | Dir | $48.0K | $41.5K |
| 9 | Bomhard Stefan Andreas | Dir | $51.0K | $16.7K |
| 10 | Cruickshank Nancy | Dir | — | $14.4K |
| 16 | SUSMAN SALLY | Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 09:19 | 2026-06-02 | FLUT | Flutter Entertainment plc | SUSMAN SALLY | Dir | A - Grant | $0.00 | +2,071 | 2,071 | New | $0 | |
| D | 2025-03-03 | 2025-02-27 | PFE | Pfizer | SUSMAN SALLY | EVP | M - OptEx | $31.31 | +85.2K | 250.9K | +51% | +$2.67M |
| DM | 2025-03-03 | 2025-02-27 | PFE | Pfizer | SUSMAN SALLY | EVP | F - Tax | $26.06 | -82.0K | 168.9K | -33% | -$2.14M |
| D | 2025-02-25 | 2025-02-22 | PFE | Pfizer | SUSMAN SALLY | EVP | M - OptEx | $30.17 | +63.6K | 225.2K | +39% | +$1.92M |
| DM | 2025-02-25 | 2025-02-22 | PFE | Pfizer | SUSMAN SALLY | EVP | F - Tax | $26.09 | -59.5K | 222.4K | -21% | -$1.55M |
| D | 2024-04-18 | 2024-04-16 | ULS | UL Solutions Inc. | SUSMAN SALLY | Dir | P - Purchase | $28.00 | +3,571 | 3,571 | New | +$100.0K |
| D | 2024-02-27 | 2024-02-23 | PFE | Pfizer | SUSMAN SALLY | EVP | M - OptEx | $27.34 | +63.8K | 218.1K | +41% | +$1.75M |
| DM | 2024-02-27 | 2024-02-23 | PFE | Pfizer | SUSMAN SALLY | EVP | F - Tax | $27.40 | -56.5K | 213.2K | -21% | -$1.55M |
| DM | 2023-02-28 | 2023-02-25 | PFE | Pfizer | SUSMAN SALLY | EVP | F - Tax | $42.75 | -54.9K | 186.8K | -23% | -$2.35M |
| D | 2023-02-28 | 2023-02-25 | PFE | Pfizer | SUSMAN SALLY | EVP | M - OptEx | $22.89 | +73.0K | 209.2K | +54% | +$1.67M |
| D | 2023-02-24 | 2023-02-22 | PFE | Pfizer | SUSMAN SALLY | EVP | M - OptEx | $30.17 | +76.0K | 195.5K | +64% | +$2.29M |
| DM | 2023-02-24 | 2023-02-22 | PFE | Pfizer | SUSMAN SALLY | EVP | F - Tax | $43.41 | -59.3K | 182.5K | -25% | -$2.57M |
| 2022-05-12 | 2022-05-11 | PFE | Pfizer | SUSMAN SALLY | EVP | G - Gift | $0.00 | -5,000 | 119.5K | -4% | $0 | |
| DM | 2022-03-01 | 2022-02-26 | PFE | Pfizer | SUSMAN SALLY | EVP | F - Tax | $49.51 | -48.4K | 154.1K | -24% | -$2.40M |
| D | 2022-03-01 | 2022-02-26 | PFE | Pfizer | SUSMAN SALLY | EVP | M - OptEx | $25.60 | +63.6K | 172.9K | +58% | +$1.63M |
| DM | 2022-02-25 | 2022-02-23 | PFE | Pfizer | SUSMAN SALLY | EVP | F - Tax | $49.81 | -57.2K | 109.3K | -34% | -$2.85M |
| D | 2022-02-25 | 2022-02-23 | PFE | Pfizer | SUSMAN SALLY | EVP | M - OptEx | $27.34 | +76.9K | 166.5K | +86% | +$2.10M |
| M | 2021-11-30 | 2021-11-26 | PFE | Pfizer | SUSMAN SALLY | EVP | S - Sale | $54.52 | -44.3K | 126.2K | -26% | -$2.42M |
Purchase Sale Sale after option exercise All abbreviations